Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1992 Feb;47(2):112–114. doi: 10.1136/thx.47.2.112

Acute severe deterioration in cystic fibrosis associated with influenza A virus infection.

S P Conway 1, E J Simmonds 1, J M Littlewood 1
PMCID: PMC463587  PMID: 1549818

Abstract

BACKGROUND: The role of non-bacterial infection in respiratory exacerbations of cystic fibrosis has been studied less than that of bacterial infection. Some non-bacterial infections, such as influenza A, may be associated with acute respiratory deterioration and may be preventable. METHODS AND RESULTS: Three patients with cystic fibrosis showed severe deterioration in lung function and general wellbeing during the influenza A virus epidemic in the winter of 1989-90. Serological confirmation of influenza A virus infection was obtained in each case. CONCLUSIONS: As immunisation against influenza A virus is safe and provokes an adequate antibody response in patients with cystic fibrosis, it is concluded that patients with cystic fibrosis should be offered immunisation at the beginning of each influenza season. Rapid diagnostic tests and the use of antiviral drugs may have a prophylactic role in minimising lung damage.

Full text

PDF
112

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abman S. H., Ogle J. W., Butler-Simon N., Rumack C. M., Accurso F. J. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr. 1988 Nov;113(5):826–830. doi: 10.1016/s0022-3476(88)80008-8. [DOI] [PubMed] [Google Scholar]
  2. Douglas R. G., Jr Prophylaxis and treatment of influenza. N Engl J Med. 1990 Feb 15;322(7):443–450. doi: 10.1056/NEJM199002153220706. [DOI] [PubMed] [Google Scholar]
  3. Efthimiou J., Hodson M. E., Taylor P., Taylor A. G., Batten J. C. Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis. Thorax. 1984 Feb;39(2):150–154. doi: 10.1136/thx.39.2.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Loosli C. G. Influenza and the interaction of viruses and bacteria in respiratory infections. Medicine (Baltimore) 1973 Sep;52(5):369–384. doi: 10.1097/00005792-197309000-00001. [DOI] [PubMed] [Google Scholar]
  5. Mackowiak P. A. Microbial synergism in human infections (first of two parts). N Engl J Med. 1978 Jan 5;298(1):21–26. doi: 10.1056/NEJM197801052980105. [DOI] [PubMed] [Google Scholar]
  6. McNamara M. J., Phillips I. A., Williams O. B. Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung disease. Am Rev Respir Dis. 1969 Jul;100(1):19–24. doi: 10.1164/arrd.1969.100.1.19. [DOI] [PubMed] [Google Scholar]
  7. Nichol K. P., Cherry J. D. Bacterial-viral interrelations in respiratory infections of children. N Engl J Med. 1967 Sep 28;277(13):667–672. doi: 10.1056/NEJM196709282771301. [DOI] [PubMed] [Google Scholar]
  8. Ong E. L., Bilton D., Abbott J., Webb A. K., McCartney R. A., Caul E. O. Influenza vaccination in adults with cystic fibrosis. BMJ. 1991 Sep 7;303(6802):557–557. doi: 10.1136/bmj.303.6802.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ong E. L., Ellis M. E., Webb A. K., Neal K. R., Dodd M., Caul E. O., Burgess S. Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms. Thorax. 1989 Sep;44(9):739–742. doi: 10.1136/thx.44.9.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Petersen N. T., Høiby N., Mordhorst C. H., Lind K., Flensborg E. W., Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand. 1981 Sep;70(5):623–628. doi: 10.1111/j.1651-2227.1981.tb05757.x. [DOI] [PubMed] [Google Scholar]
  11. Pribble C. G., Black P. G., Bosso J. A., Turner R. B. Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections. J Pediatr. 1990 Aug;117(2 Pt 1):200–204. doi: 10.1016/S0022-3476(05)80530-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Stroobant J. Viral infection in cystic fibrosis. J R Soc Med. 1986;79 (Suppl 12):19–22. [PMC free article] [PubMed] [Google Scholar]
  13. Szaff M., Høiby N., Flensborg E. W. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand. 1983 Sep;72(5):651–657. doi: 10.1111/j.1651-2227.1983.tb09789.x. [DOI] [PubMed] [Google Scholar]
  14. Wang E. E., Prober C. G., Manson B., Corey M., Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med. 1984 Dec 27;311(26):1653–1658. doi: 10.1056/NEJM198412273112602. [DOI] [PubMed] [Google Scholar]
  15. Wright P. F., Khaw K. T., Oxman M. N., Shwachman H. Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis. J Infect Dis. 1976 Aug;134(2):144–149. doi: 10.1093/infdis/134.2.144. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES